Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time ; volume:10 ; number:1 ; day:1 ; month:5 ; year:2024 ; pages:1-6 ; date:12.2024
Cardio-Oncology ; 10, Heft 1 (1.5.2024), 1-6, 12.2024
- Creator
-
Shaaban, Adnan
Petersen, Ashley
Beckwith, Heather
Florea, Natalia
Potter, David A.
Yee, Douglas
Vogel, Rachel I.
Duprez, Daniel
Blaes, Anne H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-024-00227-z
- URN
-
urn:nbn:de:101:1-2407122131111.452984566778
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shaaban, Adnan
- Petersen, Ashley
- Beckwith, Heather
- Florea, Natalia
- Potter, David A.
- Yee, Douglas
- Vogel, Rachel I.
- Duprez, Daniel
- Blaes, Anne H.
- SpringerLink (Online service)
Other Objects (12)
Aromatase inhibitors
Aromatase inhibitors
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Aromatase inhibitors in post-menopausal endometriosis
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Use of aromatase inhibitors in practice of gynecology
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
Aromatase inhibitors
Aromatase inhibitors
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Aromatase inhibitors in post-menopausal endometriosis
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Use of aromatase inhibitors in practice of gynecology
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
Long-term effects of aromatase inhibitors on body mass index among postmenopausal breast cancer survivors in Africa: observational cohort study
Aromatase inhibitors
Aromatase inhibitors
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
Aromatase inhibitors in post-menopausal endometriosis
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
Use of aromatase inhibitors in practice of gynecology
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis